STOCK TITAN

Tharimmune To Participate in Two Upcoming Investor Conferences in May

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Tharimmune, Inc. (NASDAQ:THAR) will participate in two investor conferences in May. Randy Milby, CEO, will present at the Planet MicroCap Showcase: VEGAS 2024 and attend the EF Hutton Annual Global Conference. Investors can register online to meet with the company.

Tharimmune, Inc. (NASDAQ:THAR) parteciperà a due conferenze per investitori nel mese di maggio. Randy Milby, CEO, presenterà allo Showcase Planet MicroCap: VEGAS 2024 e parteciperà alla Conferenza Globale Annuale di EF Hutton. Gli investitori possono registrarsi online per incontrare la compagnia.
Tharimmune, Inc. (NASDAQ:THAR) participará en dos conferencias de inversores en mayo. Randy Milby, CEO, presentará en el Planet MicroCap Showcase: VEGAS 2024 y asistirá a la Conferencia Global Anual de EF Hutton. Los inversores pueden registrarse en línea para reunirse con la empresa.
Tharimmune, Inc. (NASDAQ:THAR)는 5월에 두 투자자 회의에 참여할 예정입니다. CEO 랜디 밀비는 플래닛 마이크로캡 쇼케이스: VEGAS 2024에서 발표하고 EF 허튼 연례 글로벌 콘퍼런스에 참석할 것입니다. 투자자들은 회사와 만나기 위해 온라인으로 등록할 수 있습니다.
Tharimmune, Inc. (NASDAQ:THAR) participera à deux conférences d'investisseurs en mai. Randy Milby, PDG, présentera au Planet MicroCap Showcase : VEGAS 2024 et assistera à la Conférence Globale Annuelle EF Hutton. Les investisseurs peuvent s'inscrire en ligne pour rencontrer l'entreprise.
Tharimmune, Inc. (NASDAQ:THAR) wird im Mai an zwei Investorenkonferenzen teilnehmen. Randy Milby, der CEO, wird auf dem Planet MicroCap Showcase: VEGAS 2024 präsentieren und an der jährlichen globalen Konferenz von EF Hutton teilnehmen. Investoren können sich online registrieren, um sich mit dem Unternehmen zu treffen.
Positive
  • None.
Negative
  • None.

BRIDGEWATER, NJ / ACCESSWIRE / April 30, 2024 / Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation & immunology announced that management will be participating in two investor conferences in May.

Randy Milby, Chief Executive Officer, will be presenting at the Planet MicroCap Showcase: VEGAS 2024 being held at the Paris Hotel & Casino in Las Vegas, Nevada, and will hold 1x1 meetings with investors. Investors interested in meeting with Tharimmune can register for the conference here.

Event:

Planet MicroCap Showcase: VEGAS 2024

Date:

Wednesday, May 1, 2024

Time:

3:30 p.m. Pacific Time

Webcast:

https://www.webcaster4.com/Webcast/Page/3026/50301

Archive:

https://planetmicrocapshowcase.com/agenda

Mr. Milby will also be attending the EF Hutton Annual Global Conference being held at The Plaza Hotel in New York City on Wednesday, May 15, and will hold 1x1 meetings with investors.

About Tharimmune
Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. The Company's lead clinical-stage asset, TH104 is known to suppress chronic, debilitating pruritus or "uncontrollable itching" in PBC, a rare and orphan liver disease with no known cure. The Company's early-stage immunology pipeline includes novel multi-specific antibodies targeting unique epitopes with novel mechanisms of action against well-known, validated targets in multiple solid tumors, including PD-1, HER2 and HER3. Tharimmune has a license agreement with OmniAb, Inc. to access the company's antibody discovery technology platform against these and other specified targets. For more information please visit: www.tharimmune.com.

Forward Looking Statements
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, contained in this press release, including statements regarding Tharimmune's strategy, future operations, future financial position, projected costs, prospects, plans and objectives of management, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "depends," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "target," "should," "will," "would," and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company may not actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements, and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in these forward-looking statements. Factors that may cause such differences, include, but are not limited to, those discussed under Risk Factors set forth in our Annual Report on Form 10-K/A for the year ended December 31, 2023 and other periodic reports filed by the Company from time to time with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Company's views as of the date of this release. Subsequent events and developments may cause the Company's views to change; however, the Company does not undertake and specifically disclaims any obligation to update or revise any forward-looking statements to reflect new information, future events or circumstances or to reflect the occurrences of unanticipated events, except as may be required by applicable law. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of this release.

Contacts:

Tharimmune, Inc.
ir@tharimmune.com

LHA Investor Relations
Tirth T. Patel
tpatel@lhai.com
212-201-6614

SOURCE: Tharimmune, Inc.



View the original press release on accesswire.com

FAQ

When will Tharimmune participate in the investor conferences in May?

Tharimmune will participate in two investor conferences in May.

Who will be presenting at the Planet MicroCap Showcase: VEGAS 2024?

Randy Milby, the CEO of Tharimmune, will be presenting at the Planet MicroCap Showcase.

Where will the Planet MicroCap Showcase: VEGAS 2024 be held?

The Planet MicroCap Showcase: VEGAS 2024 will be held at the Paris Hotel & Casino in Las Vegas, Nevada.

What is the date of the EF Hutton Annual Global Conference?

The EF Hutton Annual Global Conference will be held on Wednesday, May 15.

How can investors register to meet with Tharimmune at the conferences?

Investors interested in meeting with Tharimmune can register for the conference online.

Tharimmune, Inc.

NASDAQ:THAR

THAR Rankings

THAR Latest News

THAR Stock Data

3.06M
1.91M
1.79%
1.63%
6.44%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BRIDGEWATER